In this Issue:
Review: MRI in MS
Natalizumab vs fingolimod in active relapsing-remitting MS
Long-term safety and efficacy of alemtuzumab
NEDA in a MS cohort over 7 years
Vaccines and the risk of CNS ADS
Spinal cord MRI and retinal layers in MS
BVL: clinical and MRI outcomes in MS
MS and information processing speed decline
Thalamus structure and function and cognitive impairment
Autologous haematopoietic cell transplantation for MS
Please login below to download this issue (PDF)